Anti-Influenza A Virus antibody (HRP) (ab21030)
- Datasheet
- References
- Protocols
Overview
-
Product nameAnti-Influenza A Virus antibody (HRP)
See all Influenza A Virus primary antibodies -
DescriptionGoat polyclonal to Influenza A Virus (HRP)
-
Host speciesGoat
-
ConjugationHRP
-
SpecificityPurified virions. Reacts with all antigenic types of Influenza A in other assay applications.May react with chicken cellular proteins.
-
Tested applicationsSuitable for: ELISAmore details
-
Species reactivityReacts with H3N2 from Influenza A. Does not react Influenza B, RSV, Para 1-3 or Adenovirus. Not yet tested in other species.
-
Immunogen
Influenza A, strain Texas 1/77 (H3N2).
-
General notes
Coupled to a highly purified preparation of horseradish peroxidase (RZ>3). Care is taken to ensure adequate conjugation while preserving maximum enzyme activity. Free enzyme is not present. Estimated Molar HRP IgG substitution is 2-3.
Properties
-
FormLiquid
-
Storage instructionsShipped at 4°C. Store at +4°C.
-
Storage bufferPreservative: 0.002% Thimerosal (merthiolate)
Constituents: PBS, 1% BSA -
Concentration information loading... -
PurityIon Exchange Chromatography
-
Purification notesPurified from the whole antiserum, followed by sodium sulfate precipitation and ion-exchange chromatography.
-
ClonalityPolyclonal
-
IsotypeIgG
-
Research areas
Associated products
-
Compatible Secondaries
-
Related Products
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
- 450 nm Stop Solution for TMB Substrate (ab171529)
- 650 nm Stop Solution for TMB Substrate (ab171531)
- Immunoassay Blocking Buffer (ab171534)
- Immunoassay Blocking (BSA Free) (ab171535)
Applications
Our Abpromise guarantee covers the use of ab21030 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| ELISA |
Application notes
ELISA: A starting range of 1:200-1:1,000 is recommended.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Target
-
RelevanceInfluenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza type C infections cause a mild respiratory illness and are not thought to cause epidemics. Influenza A viruses are further categorized into subtypes on the basis of two surface antigens: hemagglutinin (H) and neuraminidase (N). Strains are also described by geographic origin, strain number and year of isolation.
-
Cellular localizationNuclear
References
ab21030 has not yet been referenced specifically in any publications.
